ARA-290 is a peptide analogue of erythropoietin (EPO) engineered to activate the tissue-protective receptor without the blood-forming effects of EPO. Research has focused on its potential neuroprotective, anti-inflammatory, and metabolic properties, with studies examining its effects on nerve repair, pain signaling, and insulin sensitivity.
For research use only. Not intended for human or animal consumption. Not evaluated by the FDA.